Results 201 to 210 of about 493,439 (210)

EGFR-Independent Mechanisms of Acquired Resistance to AZD9291 in EGFR T790M-Positive NSCLC Patients

Annals of Oncology, 2015
Fabrice André, J C Soria, J C Soria
exaly  

Personalized Care for Patients With EGFR-Mutant Nonsmall Cell Lung Cancer: Navigating Early to Advanced Disease Management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio de Vito   +2 more
exaly  

Treating EGFR-Mutant Nonsmall Cell Lung Cancer Is No Longer a One-Size-Fits-All Approach

Ca-A Cancer Journal for Clinicians
Jyoti Malhotra, Lauren Antrim
exaly  

Randomized Phase II Study of Concurrent Versus Sequential Alternating Gefitinib and Chemotherapy in Previously Untreated Non-Small Cell Lung Cancer With Sensitive EGFR Mutations: NEJ005/TCOG0902

Annals of Oncology, 2015
I Kinoshita, S Oizumi, A Gemma
exaly  

Aumolertinib With Carboplatin–Pemetrexed Versus Aumolertinib for Nonsmall Cell Lung Cancer With EGFR and Concomitant Tumor Suppressor Genes (ACROSS2): An Open-Label, Multicenter, Randomized Phase 3 Study

Ca-A Cancer Journal for Clinicians
Yan Yu, Diansheng Zhong, Lin Wu
exaly  

Phase II Study on Lapatinib in Advanced EGFR-Positive Chordoma

Annals of Oncology, 2013
Luigi Mariani, Silvia Stacchiotti, Elena Tamborini   +2 more
exaly  

Targeting Tumor Suppressor Gene Co-Mutations in EGFR-Mutant Nonsmall Cell Lung Cancer: How ACROSS2 Sharpens the Case for Early Intensification

Ca-A Cancer Journal for Clinicians
Hina Khan, Gilberto de Lima Lopes
exaly  

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

New England Journal of Medicine, 2018
Daisuke Shibahara, Jean-Charles Soria, Caicun Zhou   +2 more
exaly  

The Changing Treatment Landscape of EGFR-Mutant Non-Small-Cell Lung Cancer

Nature Reviews Clinical Oncology
Suresh S Ramalingam, Daniel Shao Weng Tan, Xiuning Le   +2 more
exaly  

EGFR-Activated Myofibroblasts Promote Metastasis of Pancreatic Cancer

Cancer Cell
Joaquín Araos, Giulia Biffi
exaly